Skip to content

CDR

Trumps unveils war on opioid abuse

Last month, President Trump unveiled his plan to fight the nationwide opioid crisis. The departments of Health and Human Services (HHS) and Justice are the two agencies charged with leading the effort and executing the president’s plan.

Albertsons plans digital market

Albertsons Cos. is launching a new digital marketplace for food and wellness products, and the retailer is inviting suppliers of new and niche brands to be a part of it. “At Albertsons Cos.

Genoa hits milestone as 400th store debuts

Genoa hits milestone as 400th store debuts

Behavioral health pharmacy operator Genoa Healthcare has opened its 400th location, in its home state. Last month, Tukwila, Wash.-based Genoa held the grand opening of its newest pharmacy at Comprehensive Life Resources, a nonprofit behavioral health center in Renton.

Rice to head PBM business at CVS Health

Former Eli Lilly and Co. finance chief Derica Rice has been named president of CVS Caremark, the pharmacy benefits management business of CVS Health. He succeeds Jon Roberts, who was promoted last year to the newly created position of chief operating officer of CVS Health.

NACDS endorses drug disposal bill

NACDS endorses drug disposal bill

The National Association of Chain Drug Stores  has endorsed S. 2645, the Access to Increased Drug Disposal Act of 2018, which is consistent with the spirit of NACDS’ policy recommendations to help address the opioid abuse epidemic. Sen. Joni Ernst (R.

Garnier, Biofreeze top IRI 2017 H&BA Pacesetters

Garnier, Biofreeze top IRI 2017 H&BA Pacesetters

Garnier Whole Blends, Biofreeze, and Herbal Essences Bio:Renew led last year’s most succesful nonfoods launches, IRI reported today. The three H&BA brands had first-year sales of $122 million, $78 million and $75 million, respectively.

Express Scripts to roll out innovative pilot program

Express Scripts to roll out innovative pilot program

Express Scripts will be launching a new, innovative 12-month pilot for a performance-based retail pharmacy network for commercial plans designed to optimize medication therapy, improve medication adherence, and promote better outcomes.

Mylan to partner with Mapi Pharma on new MS drug

Mylan to partner with Mapi Pharma on new MS drug

Mylan N.V. and Mapi Pharma Ltd. announced that the two companies will team on the development and commercialization of GA Depot, a long-acting Glatiramer Acetate product. Mylan is acquiring global marketing rights to the product. GA Depot is a proposed once-monthly injection for the treatment of